Inflammatory breast cancer appearance at presentation is associated with overall survival

被引:6
|
作者
Balema, Wintana [1 ,2 ,3 ]
Liu, Diane [4 ]
Shen, Yu [4 ]
El-Zein, Randa [5 ]
Debeb, Bisrat G. [1 ,6 ]
Kai, Megumi [2 ,3 ]
Overmoyer, Beth [7 ]
Miller, Kathy D. [8 ]
Le-Petross, Huong T. [2 ,3 ]
Ueno, Naoto T. [1 ,6 ]
Woodward, Wendy A. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Morgan Welch IBC Clin, Dept Radiat Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Res Program, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Houston Methodist Canc Ctr, Dept Radiol, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词
breast cancer; breast swelling; erythema; IBC; peau d'orange; redness; skin thickening; T4D; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; CLINICAL MANAGEMENT; DIAGNOSIS; LYMPHANGIOGENESIS; CARCINOMA; CONSENSUS; CENTERS; PROGRAM; BIOLOGY; TIME;
D O I
10.1002/cam4.4170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS). Method Breast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS. Results We analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001). Conclusions A triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.
引用
收藏
页码:6261 / 6272
页数:12
相关论文
共 50 条
  • [1] A picture worth a thousand words - "classic" inflammatory breast cancer (IBC) appearance associated with overall survival
    Balema, Wintana
    Liu, Diane
    Shen, Yu
    El-Zein, Randa
    Kai, Megumi
    Overmoyer, Beth
    Miller, Kathy D.
    Le-Petross, Carisa
    Ueno, Naoto T.
    Woodward, Wendy A.
    CANCER RESEARCH, 2021, 81 (04)
  • [2] Aspirin Use is Associated with Improvement in Overall Survival and Recurrence Free Survival in Inflammatory Breast Cancer Patients
    Johns, C.
    Yen, A.
    Liu, Y.
    Rahimi, A. S.
    Alluri, P. G.
    Spangler, A.
    Kim, D. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E27 - E27
  • [3] Type of remission not associated with overall survival in metastatic breast cancer
    Regierer, A. C.
    Wolters, R.
    Novopashenny, I
    Weigel, A.
    Fischer, J.
    Constantinidou, M.
    Eucker, J.
    Possinger, K.
    Wischnewsky, M.
    ONKOLOGIE, 2012, 35 : 68 - 69
  • [4] Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
    Dominique J. P. van Uden
    Marissa C. van Maaren
    Peter Bult
    Luc J. A. Strobbe
    J. J. M. van der Hoeven
    Charlotte F. J. M. Blanken-Peeters
    Sabine Siesling
    Johannes H. W. de Wilt
    Breast Cancer Research and Treatment, 2019, 176 : 217 - 226
  • [5] Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
    van Uden, Dominique J. P.
    van Maaren, Marissa C.
    Bult, Peter
    Strobbe, Luc J. A.
    van der Hoeven, J. J. M.
    Blanken-Peeters, Charlotte F. J. M.
    Siesling, Sabine
    de Wilt, Johannes H. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (01) : 217 - 226
  • [6] Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
    van Uden, D. J. P.
    van Maaren, M. C.
    Strobbe, L. J. A.
    Bult, P.
    van der Hoeven, J. J.
    Siesling, S.
    de Wilt, J. H. W.
    Blanken-Peeters, C. F. J. M.
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [7] Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
    D. J. P. van Uden
    M. C. van Maaren
    L. J. A. Strobbe
    P. Bult
    J. J. van der Hoeven
    S. Siesling
    J. H. W. de Wilt
    C. F. J. M. Blanken-Peeters
    Breast Cancer Research, 21
  • [8] Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
    Diao, Jian-dong
    Ma, Li-xia
    Sun, Mei-yang
    Wu, Chun-jiao
    Wang, Li-juan
    Liu, Yan-ling
    Yang, Yong-jing
    CANCER MEDICINE, 2019, 8 (12): : 5600 - 5608
  • [9] Beta-1 integrin expression is associated with overall survival in breast cancer
    Lee, B
    Yao, E
    Chen, Y
    Zhang, H
    Chew, K
    Moore, D
    Park, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S469 - S469
  • [10] Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients
    Sporn, Judith C.
    Katsuta, Eriko
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 233 : 426 - 435